Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Harari

Showing results (211-220 of 305) with videos related to

Pageof 31
Sort By:
Nature Human Behaviour|October 16, 2025
Bridging the empathy perception gap fosters social connectionRui Pei, Samantha J Grayson, Ruth E Appel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Integrated single-cell and spatial analysis reveals context-dependent myeloid-T cell interactions in response to immune checkpoint blockade in head and neck cancerAthena E Golfinos-Owens, Taja Lozar, Parth Khatri, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 6, 2023
Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic DosimetryIan R Marsh, Chunrong Li, Joseph Grudzinski, et al.
Cancers of the Head & Neck|March 13, 2018
Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal diseaseMatthew E Witek, Aaron M Wieland, Shuai Chen, et al.
Lab on a Chip|April 17, 2020
Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironmentKarina M Lugo-Cintrón, José M Ayuso, Bridget R White, et al.
Neuro-Oncology Advances|June 7, 2024
Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomasColin M Harari, Adam R Burr, Brett A Morris, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trialJames A Bonner, Jordi Giralt, Paul M Harari, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparisonC Wesley Hodge, Søren M Bentzen, Gordon Wong, et al.
Head & Neck|June 28, 2013
Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapyDonald M Cannon, Heather M Geye, Gregory K Hartig, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)Avraham Eisbruch, Jonathan Harris, Adam S Garden, et al.
Pageof 31

Showing results (211-220 of 305) with videos related to

Sort By:
Pageof 31
Nature Human Behaviour|October 16, 2025
Bridging the empathy perception gap fosters social connectionRui Pei, Samantha J Grayson, Ruth E Appel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Integrated single-cell and spatial analysis reveals context-dependent myeloid-T cell interactions in response to immune checkpoint blockade in head and neck cancerAthena E Golfinos-Owens, Taja Lozar, Parth Khatri, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 6, 2023
Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic DosimetryIan R Marsh, Chunrong Li, Joseph Grudzinski, et al.
Cancers of the Head & Neck|March 13, 2018
Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal diseaseMatthew E Witek, Aaron M Wieland, Shuai Chen, et al.
Lab on a Chip|April 17, 2020
Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironmentKarina M Lugo-Cintrón, José M Ayuso, Bridget R White, et al.
Neuro-Oncology Advances|June 7, 2024
Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomasColin M Harari, Adam R Burr, Brett A Morris, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trialJames A Bonner, Jordi Giralt, Paul M Harari, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparisonC Wesley Hodge, Søren M Bentzen, Gordon Wong, et al.
Head & Neck|June 28, 2013
Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapyDonald M Cannon, Heather M Geye, Gregory K Hartig, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)Avraham Eisbruch, Jonathan Harris, Adam S Garden, et al.
Pageof 31